Recombinant Gamma Interferon as an Immunological Adjuvant

  • J. H. L. Playfair
  • A. W. Heath
  • J. B. De Souza
Part of the NATO ASI Series book series (NSSA, volume 179)


Given the substantial advances that have been made in the understanding of how immune responses are induced and regulated, it should be possible to design vaccine adjuvants deliberately rather than empirically. This approach has led to the demonstration that at least three of the cytokines involved in interactions between immunological cells have significant adjuvant properties when given together with antigen.


Malaria Vaccine Adjuvant Activity Immunological Cell Adjuvant Property Recombinant Gamma Interferon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Anderson, G., Urban, U., Fedorka-Cray, P., Newell, A., Nunberg, J. and Doyle, M., 1987, Interleukin 2 and protective immunity in Haemophilus pleuropneumoniae: preliminary studies, in: “Vaccines’ 87”, R.M. Chanock, R.A. Lerner, F. Brown and H. Ginsberg, eds., Cold Spring Harbor Laboratory Symposia.Google Scholar
  2. Anderson, K.P., Fennie, E.H., and Yilma, T., 1988. Enhancement of a secondary antibody response to Vesicular stomatatis virus “G” protein by IFNγ treatment at primary immunization, J. Immunol., 140: 3599.PubMedGoogle Scholar
  3. Gerrard, T.L., Siegel, J.P., Dyer, D.R. and Zoon, K., 1987, Differential effects of interferon-β and interferon-γ on IL-1 secretion by monocytes, J. Immunol. 138: 2535.PubMedGoogle Scholar
  4. Harte, P.G., De Souza, J.B. and Playfair, J.H.L., 1982, Failure of malaria vaccination in mice born to immune mothers, Clin. Exp. Imm., 49: 509.Google Scholar
  5. Nencioni, L., Villa, L., Tagliabue, A., Antoni, G., Presentini, R., Perin, F., Silvestri, S. and Boraschi, D., 1987, In vivo immunostimulatory activity of the 163-171 peptide of human recombinant IL1, J. Immunol., 139: 800.PubMedGoogle Scholar
  6. Playfair, J.H.L. and De Souza, J.B., 1986, Vaccination of mice against malaria with soluble antigens. 1. The effect of detergent route, and adjuvant, Parasite Immunol. 8: 406.CrossRefGoogle Scholar
  7. Playfair, J.H.L. and De Souza, J.B., 1987, Recombinant gamma interferon is a potent adjuvant for a murine malaria vaccine in mice, Clin. exp. Immunol., 67: 5.PubMedGoogle Scholar
  8. Skoglund, C., Scheynius, A., Holmdahl, R. and Van der Meide, P.H., 1988, Enhancement of DTH reaction and inhibition of the expression of class II transplantation antigens by in vivo treatment with antibodies against IFN-γ, Clin. Exp. Imm., 71: 428.Google Scholar
  9. Staruch, M.J. and Wood, D.D., 1983, The adjuvanticity of interleukin 1 in vivo, J. Immunol., 130: 2191.Google Scholar
  10. Strassmann, G., Somers, S.D., Spencer, T.D., Adams D.O. and Hamilton, T.A., 1986, Biochemical models of interferonγ mediated macrophage activation; independent regulation of lymphocyte function associated antigen (LFA-1) and Ia antigen on murine peritoneal macrophages, Cell. Immunol., 97: 110.PubMedCrossRefGoogle Scholar
  11. Weinberg, A. and Merigan, T.C., 1988, Recombinant interleukin 2 as an adjuvant for vaccine induced protection. Immunisation of Guineapigs with Herpes simplex virus subunit vaccines, J. Immunol., 140: 294.PubMedGoogle Scholar
  12. Zlotnik, A., Shimonkevitz, R.P., Gefter, M.L., Kappler, J. and Marrack, P.J., 1983, Characterisation of the γ-interferon mediated induction of antigen presenting ability in P388D1 cells, J. Immunol., 131: 2814.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • J. H. L. Playfair
    • 1
  • A. W. Heath
    • 1
  • J. B. De Souza
    • 1
  1. 1.Department of ImmunologyUniversity College and Middlesex School of MedicineLondonUK

Personalised recommendations